MBL Wealth
MDGL icon

MBL Wealth’s Madrigal Pharmaceuticals MDGL Stock Holding History

MBL Wealth’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$527K Buy
+1,045
New +$552K 0.03% 292

Other funds holding MDGL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

MBL Wealth's MDGL Position: Q3 2026 in Review

MBL Wealth opened a new position in Madrigal Pharmaceuticals (MDGL) in Q3 2026: 1,045 shares worth $527K. The stake represents 0.03% of the portfolio and ranks #292 among its holdings.

302 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • MBL Wealth held 1,045 shares of Madrigal Pharmaceuticals worth $527K as of Q3 2026.
  • Madrigal Pharmaceuticals was a new MBL Wealth position in Q3 2026.
  • Madrigal Pharmaceuticals made up 0.03% of MBL Wealth's portfolio in Q3 2026, its #292 holding.
  • 302 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on MBL Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.